129 related articles for article (PubMed ID: 35166430)
1. α-Myosin heavy chain (MYH6) in hypertrophic cardiomyopathy: Prominent expression in areas with vacuolar degeneration of myocardial cells.
Ntelios D; Meditskou S; Efthimiadis G; Pitsis A; Zegkos T; Parcharidou D; Theotokis P; Alexouda S; Karvounis H; Tzimagiorgis G
Pathol Int; 2022 May; 72(5):308-310. PubMed ID: 35166430
[No Abstract] [Full Text] [Related]
2. The myosin mesa and the basis of hypercontractility caused by hypertrophic cardiomyopathy mutations.
Nag S; Trivedi DV; Sarkar SS; Adhikari AS; Sunitha MS; Sutton S; Ruppel KM; Spudich JA
Nat Struct Mol Biol; 2017 Jun; 24(6):525-533. PubMed ID: 28481356
[TBL] [Abstract][Full Text] [Related]
3. Novel mutation in the α-myosin heavy chain gene is associated with sick sinus syndrome.
Ishikawa T; Jou CJ; Nogami A; Kowase S; Arrington CB; Barnett SM; Harrell DT; Arimura T; Tsuji Y; Kimura A; Makita N
Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):400-8. PubMed ID: 25717017
[TBL] [Abstract][Full Text] [Related]
4. Structural effects of the slow/b-cardiac myosin heavy chain R453C mutation in cardiac and skeletal muscle.
Tajsharghi H; Fyhr IM
Scand Cardiovasc J; 2008 Apr; 42(2):153-6. PubMed ID: 18365899
[TBL] [Abstract][Full Text] [Related]
5. Alpha-cardiac myosin heavy chain (MYH6) mutations affecting myofibril formation are associated with congenital heart defects.
Granados-Riveron JT; Ghosh TK; Pope M; Bu'Lock F; Thornborough C; Eason J; Kirk EP; Fatkin D; Feneley MP; Harvey RP; Armour JA; David Brook J
Hum Mol Genet; 2010 Oct; 19(20):4007-16. PubMed ID: 20656787
[TBL] [Abstract][Full Text] [Related]
6. [Hypertrophic cardiomyopathy: infrequent mutation of the cardiac beta-myosin heavy-chain gene].
Mora R; Merino JL; Peinado R; Olias F; García-Guereta L; del Cerro MJ; Tarín MN; Molano J
Rev Esp Cardiol; 2006 Aug; 59(8):846-9. PubMed ID: 16938236
[TBL] [Abstract][Full Text] [Related]
7. New Variant With a Previously Unrecognized Mechanism of Pathogenicity in Hypertrophic Cardiomyopathy.
Aguib Y; Allouba M; Walsh R; Ibrahim AM; Halawa S; Afify A; Hosny M; Theotokis PI; Galal A; Elshorbagy S; Roshdy M; Kassem HS; Ellithy A; Buchan R; Whiffin N; Anwer S; Cook SA; Moustafa A; ElGuindy A; Ware JS; Barton PJR; Yacoub M
Circulation; 2021 Aug; 144(9):754-757. PubMed ID: 34460321
[No Abstract] [Full Text] [Related]
8. A novel de novo mutation of β-cardiac myosin heavy chain gene found in a twelve-year-old boy with hypertrophic cardiomyopathy.
Okada S; Suzuki Y; Arimura T; Kimura A; Narumi H; Hasegawa S
J Genet; 2014 Aug; 93(2):557-60. PubMed ID: 25189259
[No Abstract] [Full Text] [Related]
9. A new mutation affecting the converter region of the beta-myosin heavy chain related to hypertrophic cardiomyopathy with poor prognosis.
Nuche J; Salguero-Bodes R; Valverde-Gómez M; Delgado JF; Arribas-Ynsaurriaga F; Palomino-Doza J
Rev Esp Cardiol (Engl Ed); 2020 Feb; 73(2):180-183. PubMed ID: 31416728
[No Abstract] [Full Text] [Related]
10. Symptomatic distal myopathy with cardiomyopathy due to a MYH7 mutation.
Overeem S; Schelhaas HJ; Blijham PJ; Grootscholten MI; ter Laak HJ; Timmermans J; van den Wijngaard A; Zwarts MJ
Neuromuscul Disord; 2007 Jun; 17(6):490-3. PubMed ID: 17383184
[TBL] [Abstract][Full Text] [Related]
11. β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity.
Adhikari AS; Trivedi DV; Sarkar SS; Song D; Kooiker KB; Bernstein D; Spudich JA; Ruppel KM
Nat Commun; 2019 Jun; 10(1):2685. PubMed ID: 31213605
[TBL] [Abstract][Full Text] [Related]
12. Cardiac myosin inhibitors for hypertrophic cardiomyopathy: shedding light on their clinical potential.
Rao SJ; Forst B; Kanwal AK; Kanwal A; Aronow WS; Naidu SS
Expert Opin Investig Drugs; 2023 Jan; 32(1):1-4. PubMed ID: 36625220
[No Abstract] [Full Text] [Related]
13. Myosin-Related Dilated Cardiomyopathy: Another Elephant Emerges From Darkness.
Lanfear DE; Reza N
J Am Coll Cardiol; 2022 Oct; 80(15):1462-1464. PubMed ID: 36202535
[No Abstract] [Full Text] [Related]
14. Cardiac Myosin Inhibitors for Obstructive Hypertrophic Cardiomyopathy: Where Are We on the Hype Cycle?
Ommen SR
J Am Coll Cardiol; 2022 Jul; 80(2):109-110. PubMed ID: 35798444
[No Abstract] [Full Text] [Related]
15. The molecular phenotype of human cardiac myosin associated with hypertrophic obstructive cardiomyopathy.
Jacques AM; Briceno N; Messer AE; Gallon CE; Jalilzadeh S; Garcia E; Kikonda-Kanda G; Goddard J; Harding SE; Watkins H; Esteban MT; Tsang VT; McKenna WJ; Marston SB
Cardiovasc Res; 2008 Aug; 79(3):481-91. PubMed ID: 18411228
[TBL] [Abstract][Full Text] [Related]
16. Faster cross-bridge detachment and increased tension cost in human hypertrophic cardiomyopathy with the R403Q MYH7 mutation.
Witjas-Paalberends ER; Ferrara C; Scellini B; Piroddi N; Montag J; Tesi C; Stienen GJ; Michels M; Ho CY; Kraft T; Poggesi C; van der Velden J
J Physiol; 2014 Aug; 592(15):3257-72. PubMed ID: 24928957
[TBL] [Abstract][Full Text] [Related]
17. Cranial, axial and proximal myopathy and hypertrophic cardiomyopathy caused by a mutation in the globular head region of the MYH7 gene.
Díaz-Manera J; Alejaldre A; Llauger J; Mirabet S; Rojas-García R; Ramos-Fransi A; Gallardo E; Illa I
Eur J Neurol; 2014 Jun; 21(6):e51-2. PubMed ID: 24805292
[No Abstract] [Full Text] [Related]
18. Gene-specific increase in the energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutations.
Witjas-Paalberends ER; Güçlü A; Germans T; Knaapen P; Harms HJ; Vermeer AM; Christiaans I; Wilde AA; Dos Remedios C; Lammertsma AA; van Rossum AC; Stienen GJ; van Slegtenhorst M; Schinkel AF; Michels M; Ho CY; Poggesi C; van der Velden J
Cardiovasc Res; 2014 Jul; 103(2):248-57. PubMed ID: 24835277
[TBL] [Abstract][Full Text] [Related]
19.
Dias GM; Lamounier Júnior A; Seifert M; Barájas-Martinez H; Barr D; Sternick EB; Medina-Acosta E; Campos de Carvalho AC; Cruz Filho FES
Circ Genom Precis Med; 2021 Oct; 14(5):e003476. PubMed ID: 34555931
[No Abstract] [Full Text] [Related]
20. [Familial hypertrophic cardiomyopathy: genes, mutations and animal models. A review].
Ramírez CD; Padrón R
Invest Clin; 2004 Mar; 45(1):69-99. PubMed ID: 15058760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
